Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_assertion description "[The two genes of the GAGE family that code for this peptide, namely GAGE-1 and GAGE-2, are expressed in a significant proportion of melanomas (24%), sarcomas (25%), non-small cell lung cancers (19%), head and neck tumors (19%), and bladder tumors (12%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_assertion evidence source_evidence_literature NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_assertion SIO_000772 7544395 NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_assertion wasDerivedFrom befree-2016 NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_assertion wasGeneratedBy ECO_0000203 NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.
- befree-2016 importedOn "2016-02-19" NP1311851.RA_wyeGTKy8Sr8X0HULKMVwk8Jp-RTevdPA1xtJW-gn94130_provenance.